Janssen

J&J’s Ebola vaccine approved in EU
J&J’s Ebola vaccine approved in EU
Pharmaforum
Europe
JNJ
ebola virus
Janssen
vaccines
Bavarian Nordic
Flag link:
J&J scraps late-stage study testing Stelara for lupus
J&J scraps late-stage study testing Stelara for lupus
Reuters
JNJ
Janssen
lupus
Stelara
clinical trials
Flag link:
J&J brings forward start of COVID-19 vaccine trial to next month
J&J brings forward start of COVID-19 vaccine trial to next month
Pharmaforum
JNJ
vaccines
Janssen
COVID-19
Ad26.COV2-S
Flag link:
Janssen Presents First Data from Phase 1 Study of BCMAxCD3 Bispecific Teclistamab in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma
Janssen Presents First Data from Phase 1 Study of BCMAxCD3 Bispecific Teclistamab in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma
BioSpace
JNJ
Janssen
teclistamab
JNJ-7957
clinical trials
ASCO 2020
Multiple Myeloma
Flag link:
Janssen promotes R&D exec into newfound data science role
Janssen promotes R&D exec into newfound data science role
Fierce Biotech
JNJ
Janssen
R&D
data science
Najat Khan
Flag link:
Janssen announces submission of two applications to US FDA seeking approval of SIMPONI ARIA to treat polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis
Janssen announces submission of two applications to US FDA seeking approval of SIMPONI ARIA to treat polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis
Pharmaceutical Business Review
JNJ
Janssen
FDA
Simponi Aria
polyarticular juvenile idiopathic arthritis
juvenile psoriatic arthritis
Flag link:
Janssen's experience illustrates the COVID-19 logistics maze drugmakers must solve: report
Janssen's experience illustrates the COVID-19 logistics maze drugmakers must solve: report
Fierce Pharma
JNJ
Janssen
China
drug manufacturing
Flag link:
‘Drug development is a long, long process’: pharma CEO in Italy sounds a note of caution on Covid-19
‘Drug development is a long, long process’: pharma CEO in Italy sounds a note of caution on Covid-19
Stat
drug development
COVID-19
Italy
JNJ
Janssen
vaccines
Flag link:
Janssen files MS pill, ahead of FDA decision on BMS’ rival
Janssen files MS pill, ahead of FDA decision on BMS’ rival
Pharmaforum
Janssen
JNJ
multiple sclerosis
MS
FDA
ponesimod
Bristol-Myers Squibb
ozanimod
Flag link:
Thermo Fisher & J&J Team Up to Develop Lung Cancer Companion Diagnostic
Thermo Fisher & J&J Team Up to Develop Lung Cancer Companion Diagnostic
BioSpace
JNJ
Janssen
Thermo Fisher
diagnostics
cancer
clinical trials
Flag link:
J&J’s Experimental Lung Cancer Drug Receives Breakthrough Therapy Designation
J&J’s Experimental Lung Cancer Drug Receives Breakthrough Therapy Designation
BioSpace
Janssen
JNJ
FDA
JNJ-6372
breakthrough therapy
metastatic non-small cell lung cancer
Flag link:
Janssen gets FDA breakthrough therapy status for JNJ-6372 to treat metastatic NSCLC
Janssen gets FDA breakthrough therapy status for JNJ-6372 to treat metastatic NSCLC
Pharmaceutical Business Review
Janssen
JNJ
FDA
JNJ-6372
metastatic non-small cell lung cancer
Flag link:
Janssen trials ultrasound-guided approach to treating Crohn’s
Janssen trials ultrasound-guided approach to treating Crohn’s
Pharmaforum
JNJ
Janssen
guided ultrasound
Stelara
Crohn's Disease
Flag link:
Johnson & Johnson Announces Partnership With U.S. government to Accelerate Coronavirus Vaccine Development
Johnson & Johnson Announces Partnership With U.S. government to Accelerate Coronavirus Vaccine Development
Motley Fool
JNJ
Janssen
vaccines
BARDA
HHS
coronaviruses
COVID-19
Flag link:
Johnson & Johnson Submits FDA Application for Multiple Myeloma Drug
Johnson & Johnson Submits FDA Application for Multiple Myeloma Drug
Motley Fool
JNJ
Janssen
Darzalex
daratumumab
Multiple Myeloma
Flag link:
Janssen seeks EMA nod for Imbruvica, rituximab combo in previously untreated CLL
Janssen seeks EMA nod for Imbruvica, rituximab combo in previously untreated CLL
Pharmaceutical Business Review
Janssen
JNJ
EMA
Imbruvica
CLL
Flag link:
J&J, RoosterBio and Element Kick Off 2020 with Expansions
J&J, RoosterBio and Element Kick Off 2020 with Expansions
BioSpace
JNJ
Janssen
R&D
Rooster Bio
Element Biosciences
Flag link:
Janssen Expands Research & Development Presence with Major Investment in South San Francisco
Janssen Expands Research & Development Presence with Major Investment in South San Francisco
AP
JNJ
Janssen
R&D
San Francisco
Flag link:
Trump touted a new antidepressant as a solution for veterans. Only 15 have been treated
Trump touted a new antidepressant as a solution for veterans. Only 15 have been treated
Stat
Donald Trump
veterans
esketamine
major depression
Spravato
JNJ
Janssen
Flag link:
After midstage flop, Janssen says thanks but no thanks to Provention Bio drug
After midstage flop, Janssen says thanks but no thanks to Provention Bio drug
Fierce Biotech
Janssen
Provention Bio
Crohn’s disease
PRV-6527
JNJ
Flag link:

Pages